Exploring macrophage heterogeneity in IgA nephropathy: Mechanisms of renal impairment and current therapeutic targets
-
Published:2024-10
Issue:
Volume:140
Page:112748
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Qing Jianbo,
Li Changqun,
Zhi Huiwen,
Zhang Lijuan,
Wu Junnan,
Li YafengORCID
Reference79 articles.
1. J F, T R, SCW T, Current treatment of IgA nephropathy, Seminars Immunopathol. 43(5) (2021) 717-728.
2. P P, C A-C, HN R, American J. Kidney Diseases: Off. J. Nat. Kidney Found. 78(3) (2021) 429–441.
3. L G, V DL, R C, Seminars in immunopathology 43(5) (2021) 657–668.
4. Y D, T C, C L, T Z, C G, S L, X R, J L, IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment, Diagnostics (Basel, Switzerland) 2023, 13(2).
5. Pathophysiology and treatment of IgA nephropathy;Bollin;Internist (Berl),2018